Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Sirolimus × Clear all

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Phase 2 Terminated

249 enrolled 4 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00075647 2013-01-17

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms